This study summarizes our initial efforts to address an issue that is critical to the success of any multicenter gene therapy clinical trial – maintenance of vector viability during shipping and ...

The timely Viral Vector Formulation and Process Development Summit Europe is the only definitive, end-to-end platform, uniting 60+ experts across up-and downstream process development, formulation, ...

Gene transfer to lung has been hindered by inflammatory and immunological responses activated to the gene-transfer agent or transgene products. In prior work, adenovirus vector delivered to the lung ...